Acquisition of T790M resistance mutation in a patient with advanced adenocarcinoma harboring uncommon EGFR mutations: a case report and literature review
Taiki Hakozaki, Makiko Yomota Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan Background: Osimertinib is the standard of care for patients with non-small-cell lung cancer (NSCLC) patients harboring a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/acquisition-of-t790m-resistance-mutation-in-a-patient-with-advanced-ad-peer-reviewed-article-OTT |